By WHAV Staff |
April 13, 2021
Haverhill state Rep. Andy X. Vargas testified before the Housing Committee on a bill he co-filed on housing reform May 14, 2019. (Courtesy file photograph.)
Haverhill state Rep. Andy X. Vargas and Lynn Sen. Brendan Crighton were honored last week for leadership on affordable housing, housing production and roles in passing, what were described as, “the most significant zoning reforms in a generation.”
Vargas and Crighton were awarded the 2021 Citizens’ Housing and Planning Association’s Housing Hero Award.
“As the chief sponsor of housing production legislation last session in the House, Rep. Vargas helped pass the most significant zoning reforms in a generation, including multifamily zoning requirements for MBTA communities, abutter appeals reforms and Housing Choice,” said Rachel Heller, CEO of the Association. She added, “These provisions will create thousands of new homes across Massachusetts…”
Horizons Regional Council seeking views on Māori representation
13 Apr, 2021 05:00 PM
4 minutes to read
Horizons Regional Council is seeking submissions on whether or not to establish a Māori constituency. Photo / File
Horizons Regional Council is seeking submissions on whether or not to establish a Māori constituency. Photo / File
Horizons Regional Council has put out the call for public submissions on establishing designated Māori representation around the council table. The council has until May 21 to decide whether or not to establish a Māori constituency in time for the 2022 local body elections, after a recent law change gave local authorities the sole right to decide on Māori wards without the risk of citizens-initiated referenda.
MedCity News
Cellino Biotech developing tech to help scale stem cell therapies
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
Shares0
In response to emailed questions, Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen, talked about the formation of the company and its goal to make stem cell therapies more accessible for patients.
Why did you start this company?
I see a huge need to develop a technology platform to enable the manufacture of cell therapies at scale. We recently closed a $16 million seed financing round led by Khosla Ventures and The Engine at MIT, with participation from Humboldt Fund. Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the most challenging diseases within this decade, including Parkinson’s, diabetes, and heart d
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.